Literature DB >> 23772621

CD8(+) T-cell effector function and transcriptional regulation during HIV pathogenesis.

Korey R Demers1, Morgan A Reuter, Michael R Betts.   

Abstract

A detailed understanding of the immune response to human immunodeficiency virus (HIV) infection is needed to inform prevention and therapeutic strategies that aim to contain the acquired immunodeficiency syndrome (AIDS) pandemic. The cellular immune response plays a critical role in controlling viral replication during HIV infection and will likely need to be a part of any vaccine approach. The qualitative feature of the cellular response most closely associated with immunological control of HIV infection is CD8(+) T-cell cytotoxic potential, which is responsible for mediating the elimination of infected CD4(+) T cells. Understanding the underlying mechanisms involved in regulating the elicitation and maintenance of this kind of effector response can provide guidance for vaccine design. In this review, we discuss the evidence for CD8(+) T cells as correlates of protection, the means by which their antiviral capacity is evaluated, and transcription factors responsible for their function, or dysfunction, during HIV infection.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23772621      PMCID: PMC3693771          DOI: 10.1111/imr.12069

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  198 in total

Review 1.  An essential interaction between T-box proteins and histone-modifying enzymes.

Authors:  Sara A Miller; Amy S Weinmann
Journal:  Epigenetics       Date:  2009-02-16       Impact factor: 4.528

Review 2.  Non-apoptotic Fas signaling.

Authors:  Harald Wajant; Klaus Pfizenmaier; Peter Scheurich
Journal:  Cytokine Growth Factor Rev       Date:  2003-02       Impact factor: 7.638

3.  Programming for CD8 T cell memory development requires IL-12 or type I IFN.

Authors:  Zhengguo Xiao; Kerry A Casey; Stephen C Jameson; Julie M Curtsinger; Matthew F Mescher
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

4.  Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge.

Authors:  Scott G Hansen; Cassandra Vieville; Nathan Whizin; Lia Coyne-Johnson; Don C Siess; Derek D Drummond; Alfred W Legasse; Michael K Axthelm; Kelli Oswald; Charles M Trubey; Michael Piatak; Jeffrey D Lifson; Jay A Nelson; Michael A Jarvis; Louis J Picker
Journal:  Nat Med       Date:  2009-02-15       Impact factor: 53.440

5.  Rapid up-regulation and granule-independent transport of perforin to the immunological synapse define a novel mechanism of antigen-specific CD8+ T cell cytotoxic activity.

Authors:  George Makedonas; Pinaki P Banerjee; Rahul Pandey; Adam R Hersperger; Keri B Sanborn; Gareth A D Hardy; Jordan S Orange; Michael R Betts
Journal:  J Immunol       Date:  2009-05-01       Impact factor: 5.422

6.  Notch regulates cytolytic effector function in CD8+ T cells.

Authors:  Ok Hyun Cho; Hyun Mu Shin; Lucio Miele; Todd E Golde; Abdul Fauq; Lisa M Minter; Barbara A Osborne
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

7.  Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.

Authors:  Dong Zhang; Premlata Shankar; Zhan Xu; Brooke Harnisch; Gang Chen; Christoph Lange; Sandra J Lee; Hernan Valdez; Michael M Lederman; Judy Lieberman
Journal:  Blood       Date:  2002-08-22       Impact factor: 22.113

8.  Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes.

Authors:  Huabiao Chen; Alicja Piechocka-Trocha; Toshiyuki Miura; Mark A Brockman; Boris D Julg; Brett M Baker; Alissa C Rothchild; Brian L Block; Arne Schneidewind; Tomohiko Koibuchi; Florencia Pereyra; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2009-01-21       Impact factor: 5.103

Review 9.  The influence of HLA genotype on AIDS.

Authors:  Mary Carrington; Stephen J O'Brien
Journal:  Annu Rev Med       Date:  2001-12-03       Impact factor: 13.739

10.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  37 in total

1.  HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.

Authors:  Weihua Li; Chuanyun Li; Wei Xia; Xiuhui Li
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

2.  Programmed cell death-1 single-nucleotide polymorphism rs10204525 is associated with human immunodeficiency virus type 1 RNA viral load in HIV-1-infected Moroccan subjects.

Authors:  Hanâ Baba; Anass Kettani; Meryem Bouqdayr; Ahd Ouladlahsen; Rajaa Bensghir; Latifa Marih; Mustapha Sodqi; Soumaya Benjelloun; Sayeh Ezzikouri; Imane Zaidane; Fatima-Zahra Jadid; Kamal Marhoum El Filali; Lahcen Wakrim
Journal:  Med Microbiol Immunol       Date:  2021-05-24       Impact factor: 3.402

Review 3.  Sizing up the key determinants of the CD8(+) T cell response.

Authors:  David C Tscharke; Nathan P Croft; Peter C Doherty; Nicole L La Gruta
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

4.  CD8+ T cell immune response against non-viral pathogens.

Authors:  Imtiaz A Khan
Journal:  Semin Immunopathol       Date:  2015-05-06       Impact factor: 9.623

5.  Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Authors:  Brenna J Hill; Patricia A Darrah; Zachary Ende; David R Ambrozak; Kylie M Quinn; Sam Darko; Emma Gostick; Linda Wooldridge; Hugo A van den Berg; Vanessa Venturi; Martin Larsen; Miles P Davenport; Robert A Seder; David A Price; Daniel C Douek
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

6.  Short communication: HIV-1 Nef protein carries multiple epitopes suitable for induction of cellular immunity for an HIV vaccine in Africa.

Authors:  Athina Kilpeläinen; Rebecca Axelsson Robertson; Thomas Leitner; Eric Sandström; Markus Maeurer; Britta Wahren
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-16       Impact factor: 2.205

7.  Chemokine Signatures of Pathogen-Specific T Cells I: Effector T Cells.

Authors:  Jens Eberlein; Bennett Davenport; Tom T Nguyen; Francisco Victorino; Kevin Jhun; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

8.  Differential Expression of CD8+ T Cell Cytotoxic Effector Molecules in Blood and Gastrointestinal Mucosa in HIV-1 Infection.

Authors:  Brenna E Kiniry; Peter W Hunt; Frederick M Hecht; Ma Somsouk; Steven G Deeks; Barbara L Shacklett
Journal:  J Immunol       Date:  2018-01-19       Impact factor: 5.422

9.  A novel SIV gag-specific CD4(+)T-cell clone suppresses SIVmac239 replication in CD4(+)T cells revealing the interplay between antiviral effector cells and their infected targets.

Authors:  Victor I Ayala; Matthew T Trivett; Lori V Coren; Sumiti Jain; Patrick S Bohn; Roger W Wiseman; David H O'Connor; Claes Ohlen; David E Ott
Journal:  Virology       Date:  2016-03-25       Impact factor: 3.616

10.  Chemokine Signatures of Pathogen-Specific T Cells II: Memory T Cells in Acute and Chronic Infection.

Authors:  Bennett Davenport; Jens Eberlein; Tom T Nguyen; Francisco Victorino; Verena van der Heide; Maxim Kuleshov; Avi Ma'ayan; Ross Kedl; Dirk Homann
Journal:  J Immunol       Date:  2020-09-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.